MedTrace Logo

Trial of Pre-Pregnancy Supplements

NCT01183572 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 802

Last updated 2012-09-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether daily oral supplements of multivitamins (including vitamins B-complex, C and E) along with Iron and folic acid given to non-pregnant women results in lower prevalence of anemia in preparation for pregnancy when compared to daily iron and folic acid supplements or folic acid alone.

Conditions

Interventions

DIETARY_SUPPLEMENT

Multivitamins, Folic Acid, and Iron

Daily oral dose containing 2500 IU Vitamin A, 1.4 mg Vitamin B1, 1.4 mg Vitamin B2, 2.6 mg Vitamin B12, 1.9 mg Vitamin B6, 18 mg Niacin, 70 mg Vitamin C, 14.9 IU Vitamin E, 30 mg elemental iron, 0.4 mg folic acid

DIETARY_SUPPLEMENT

Folic Acid and Iron

Daily oral dose of 30 mg elemental iron, 0.4 mg folic acid

DIETARY_SUPPLEMENT

Folic Acid

Daily oral dose of 0.4 mg folic acid

Sponsors & Collaborators

  • Ifakara Health Institute

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Wafaie W Fawzi, MD, DrPH · Harvard School of Public Health (HSPH)

  • Honorati M Masanja, PhD · Ifakara Health Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
29 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Tanzania

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01183572 on ClinicalTrials.gov